Home > Analysis > Merck & Co Inc (MRK)
Merck & Co Inc (MRK) Share Price Analysis & Forecasts
Merck & Co Inc (MRK) Share Price Analysis & Forecasts

Name: Merck & Co Inc (MRK)

Description: Drug maker Merck has had a lacklustre year to date, with its stock down -8.75% versus gains of 5.56% for the Dow 30 as a whole. Merck beat on Q3 earnings but slashed its full year guidance. Despite that analysts haven't downgraded the stock or trimmed their $126.15 consensus price target. 16/11/23


The current Merck & Co Inc. (MRK) stock price is $103.46 which is a change of 0.98 or 0.96% from the last closing price of 103.46 with 6,863,429 shares traded giving NYSE:MRK a market capitalisation of $262,170,017,260. The most recent daily high has been 103.68 and daily low 102.66. The NYSE:MRK share price 52 week high has been 119.65 and the 52 week low 99.14. Based on the most recent NYSE:MRK share price opening of 103.46, the current NYSE:MRK EPS (earnings per share) are 1.8 and the PE (price earnings ratio) is 57.33. Pricing data last updated 01/12/2023 16:00.


  • Comfortably beat on earnings
  • Dividend raised +47.70% in 5-years
  • Share price up +8.00% in a month


  • Fwd PE of 22.952 looks high
  • Negative ROE
  • Inflation hurting margins
  • Outlook
Scroll to Top